SCHEMBL28538091

SCHEMBL28538091

[CH2]CC(=O)OC(=O)C1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
TSHR P16473 1/20 0.34
EPHX1 P07099 1/20 0.34
POLB P06746 2/20 0.34
CHRM2 P08172 2/20 0.34
CHRM4 P08173 2/20 0.34
CHRM1 P11229 2/20 0.34
CHRM3 P20309 2/20 0.34
ELANE P08246 1/20 0.33
ADRB2 P07550 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7807159 0.81 ALDH1A1 (0.46) CES2CES1ALDH1A1SMN1; SMN2ESR1
SCHEMBL4934011 0.80 SMN1; SMN2 (0.40) CES2CES1ALDH1A1SMN1; SMN2ESR1
SCHEMBL776566 0.79 CES2 (0.55) CES2CES1ALDH1A1SMN1; SMN2ESR1
SCHEMBL27553353 0.79 CES2 (0.55) CES2CES1ALDH1A1SMN1; SMN2ESR1
SCHEMBL11862575 0.79 CES2 (0.55) CES2CES1ALDH1A1SMN1; SMN2ESR1
SCHEMBL248821 0.79 CES2 (0.55) CES2CES1ALDH1A1SMN1; SMN2ESR1
SCHEMBL6939791 0.79 CES2 (0.55) CES2CES1ALDH1A1SMN1; SMN2ESR1
SCHEMBL777438 0.79 CES2 (0.41) CES2CES1ALDH1A1SMN1; SMN2ESR1
SCHEMBL18126504 0.79 NAAA (0.44) CES2CES1ALDH1A1SMN1; SMN2ESR1
SCHEMBL776049 0.78 ALDH1A1 (0.43) CES2CES1ALDH1A1SMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112469707-A Prophylactic or therapeutic agent for spinal muscular atrophy 利伯纳生物科学株式会社 2021-03-09 CN disclosed